Clinic
Agh Laveen LLC
Agh Laveen LLC was paid $14.88M by Medicaid between Jan 2018 and Dec 2024, across 139 billing codes. Its largest line is 99283, emergency room visit (moderate) — 34% of everything it billed.
33Billing provider infoAGH LAVEEN LLC
GLENDALE, AZ 85305
GLENDALE, AZ 85305
33aNPI1114466950assigned 02/13/2017
33bProvider typeEmergency Care Clinic/Center
28Total paid$14.88M
24GClaims283,110
24DCodes billed139
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Care Clinic/Center providers in Arizona
Rank by total paid#3 of 28
Median peer was paid$2.32M
This provider vs. median6.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HANSON, JANE controls 19+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,993 | $677K | |
| 2019 | 8,112 | $630K | |
| 2020 | 3,769 | $424K | |
| 2021 | 3,503 | $331K | |
| 2022 | 44,061 | $2.27M | |
| 2023 | 112,201 | $5.54M | |
| 2024incomplete | 101,471 | $5.01M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 34% | 27,586 | 26,453 | $5.04M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 30% | 19,021 | 18,375 | $4.50M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 14% | 5,691 | 5,504 | $2.01M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 10% | 2,559 | 2,518 | $1.49M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4.3% | 1,608 | 1,595 | $647K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.9% | 5,124 | 4,926 | $438K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.7% | 1,767 | 1,744 | $257K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.5% | 810 | 797 | $217K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 250 | 245 | $87K |
| 10060 | <1% | 341 | 337 | $69K | |
| 72131 | <1% | 166 | 163 | $45K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 21 | 21 | $18K |
127 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,569 | $11K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 284 | $10K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 8,976 | $5K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 493 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 7,073 | $3K |
| 70486 | <1% | 145 | $3K | |
| 70491 | <1% | 13 | $3K | |
| 12001 | <1% | 390 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,470 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,534 | $1K |
| 29125 | <1% | 143 | $748.64 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 4,771 | $746.57 |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 13 | $690.11 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 3,433 | $675.00 |
| 71250 | <1% | 84 | $668.91 | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 16 | $645.96 |
| 80053 | Comprehensive metabolic panel | <1% | 11,464 | $390.40 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 10,076 | $387.38 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,960 | $285.10 |
| 93976 | <1% | 689 | $281.47 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,674 | $263.38 |
| 87631 | <1% | 4,384 | $261.12 | |
| 93975 | <1% | 252 | $256.29 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,878 | $133.70 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,338 | $133.41 |
| A9270 | Non-covered item or service | <1% | 90 | $123.18 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 12,876 | $109.87 |
| 71045 | Radiologic examination, chest; single view | <1% | 4,662 | $107.77 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 8,404 | $97.59 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,269 | $89.71 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,277 | $89.48 |
| 81025 | <1% | 6,928 | $88.45 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 703 | $87.13 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 539 | $72.78 |
| 76830 | Ultrasound, transvaginal | <1% | 331 | $72.78 |
| 74018 | <1% | 1,060 | $66.05 | |
| 87634 | <1% | 1,105 | $62.39 | |
| 73562 | <1% | 715 | $58.57 | |
| 73130 | <1% | 1,014 | $36.06 | |
| 84702 | <1% | 1,242 | $35.32 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,865 | $32.70 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 9,224 | $31.05 |
| 83880 | <1% | 1,047 | $30.15 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,610 | $28.46 |
| 84484 | <1% | 2,958 | $24.94 | |
| 81003 | <1% | 10,015 | $22.84 | |
| 82962 | <1% | 638 | $19.65 | |
| 80051 | <1% | 1,888 | $19.23 | |
| 82550 | <1% | 2,139 | $17.81 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 818 | $16.13 |
| 80076 | <1% | 1,350 | $15.29 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,072 | $15.27 |
| 82565 | <1% | 1,950 | $11.94 | |
| 82803 | <1% | 1,510 | $11.85 | |
| 82947 | <1% | 1,946 | $10.17 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,258 | $10.09 |
| 84520 | <1% | 1,948 | $10.06 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 623 | $9.65 |
| 83605 | <1% | 1,567 | $9.41 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 776 | $6.64 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,087 | $6.11 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 473 | $5.83 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,367 | $5.45 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 673 | $5.44 |
| J3490 | Unclassified drugs | <1% | 4,671 | $2.79 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 688 | $0.06 |
| 72100 | 0% | 377 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 249 | $0.00 |
| 90715 | 0% | 792 | $0.00 | |
| 73110 | 0% | 593 | $0.00 | |
| 73080 | 0% | 199 | $0.00 | |
| 73630 | 0% | 1,096 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 3,147 | $0.00 |
| 73140 | 0% | 235 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 516 | $0.00 |
| 82374 | 0% | 208 | $0.00 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 0% | 387 | $0.00 |
| 73030 | 0% | 549 | $0.00 | |
| 73610 | 0% | 809 | $0.00 | |
| 80306 | 0% | 1,188 | $0.00 | |
| 87660 | 0% | 367 | $0.00 | |
| 87186 | 0% | 628 | $0.00 | |
| 85610 | 0% | 78 | $0.00 | |
| J7510 | Prednisolone oral, per 5 mg | 0% | 42 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 12 | $0.00 |
| 12011 | 0% | 200 | $0.00 | |
| 81513 | 0% | 58 | $0.00 | |
| 73590 | 0% | 133 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 111 | $0.00 |
| 84295 | 0% | 206 | $0.00 | |
| J0736 | Injection, clindamycin phosphate, 300 mg | 0% | 13 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 12 | $0.00 |
| 87481 | 0% | 58 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 13 | $0.00 |
| 96376 | 0% | 633 | $0.00 | |
| 87480 | 0% | 369 | $0.00 | |
| 87510 | 0% | 367 | $0.00 | |
| 84703 | 0% | 821 | $0.00 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 0% | 463 | $0.00 |
| 84132 | 0% | 206 | $0.00 | |
| 87077 | 0% | 713 | $0.00 | |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 163 | $0.00 |
| 82553 | 0% | 1,229 | $0.00 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 0% | 29 | $0.00 |
| 76801 | 0% | 664 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 12,335 | $0.00 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 655 | $0.00 |
| 85379 | 0% | 1,261 | $0.00 | |
| 87040 | 0% | 895 | $0.00 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 15 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 13 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 97 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 244 | $0.00 |
| 74022 | 0% | 98 | $0.00 | |
| 93971 | 0% | 208 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 280 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 40 | $0.00 |
| 82150 | 0% | 56 | $0.00 | |
| 86308 | 0% | 41 | $0.00 | |
| 73090 | 0% | 62 | $0.00 | |
| 73502 | 0% | 13 | $0.00 | |
| 82435 | 0% | 206 | $0.00 | |
| 72040 | 0% | 27 | $0.00 | |
| 87428 | 0% | 147 | $0.00 | |
| 71101 | 0% | 14 | $0.00 | |
| 12002 | 0% | 12 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHANSON, JANE (CEO)
| Provider | Location | Paid |
|---|---|---|
| Agh Laveen LLC | Laveen, AZ | $109.33M |
| Agh Mesa LLC | Mesa, AZ | $28.01M |
| Agh Mesa LLC | Mesa, AZ | $4.69M |
| Agh Laveen LLC | Goodyear, AZ | $4.04M |
| Agh Laveen LLC | Surprise, AZ | $3.48M |
| Agh Laveen LLC | Glendale, AZ | $3.40M |
| Agh Mesa LLC | Tempe, AZ | $3.34M |
| Agh Mesa LLC | Chandler, AZ | $2.76M |
| Agh Mesa LLC | Mesa, AZ | $2.66M |
| Agh Mesa LLC | San Tan Valley, AZ | $2.32M |
| Agh Mesa LLC | Phoenix, AZ | $1.74M |
| Agh Mesa LLC | Chandler, AZ | $1.12M |
| Agh Mesa LLC | Gilbert, AZ | $978K |
| Agh Laveen LLC | Mesa, AZ | $293K |
| Agh Laveen LLC | Chandler, AZ | $259K |
| Agh Laveen LLC | Phoenix, AZ | $184K |
| Agh Laveen LLC | Mesa, AZ | $167K |
| Agh Laveen LLC | Gilbert, AZ | $160K |
| Agh Laveen LLC | Chandler, AZ | $41K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.